Nuformix PLC - Second Price Monitoring Extn

Nuformix PLC - Price Monitoring Extension

Nuformix PLC - Strategic Cannabinoid Agreement

Nuformix PLC - Notification Major Share Interests

Nuformix PLC - Nuformix Commences NXP001 Clinical Trial

Nuformix PLC - MHRA approval for NXP001

Nuformix PLC - Holding(s) in Company

Nuformix PLC - Unaudited Half Year Results

Nuformix PLC - Reports Results from Novel IPF Pre-Clinical Trial

Nuformix PLC - Expansion of NXP001 Agreement & Milestone Payment

Nuformix PLC - Director/PDMR Shareholding

Nuformix PLC - Additional New NXP002 Patent Filing

Nuformix PLC - Result of AGM

Nuformix PLC - NXP001 Pre-Clinical Milestone Achieved

Nuformix PLC - Convertible Loan Amendment

Nuformix PLC - Annual Report and Notice of AGM

Nuformix PLC - Final Results

Nuformix PLC - Holding(s) in Company

Nuformix PLC - Operational Update

Nuformix PLC - Collaboration with SGSC

Nuformix PLC - Dr Chris Blackwell Appointed NED

Nuformix PLC - Holding(s) in Company

Nuformix PLC - Stmnt re Share Price Movement

Nuformix PLC - Update re: Broker

Nuformix PLC - Holding(s) in Company

Nuformix PLC - Agreement to License NXP001

Nuformix PLC - Dr Andy Richards Chairs Advisory Panel - New Appts

Nuformix PLC - Second Price Monitoring Extn

Nuformix PLC - Price Monitoring Extension

Nuformix PLC - Grant of Warrants

Nuformix PLC - Appointment of Broker

Nuformix PLC - Holding(s) in Company

Nuformix PLC - Holding(s) in Company

Nuformix PLC - Holding(s) in Company

Nuformix PLC - NXP001 agreement for pilot bioequivalence study

Nuformix PLC - Admission and First Dealings

Nuformix PLC - Cancellation Notice and Re-Admission